Prices delayed by at least 15 minutes | Print


Hvivo PLC (HVO)

ORD 0.1P
Sell: 28.5p|Buy: 29.5p|Change: 0.33 (1.14%)

Open 

28.9p


Previous close 

28.9p


Trade high 

29.5p


Volume 

627,110


Year high 

32.00p


Year low 

12.50p


Dividend yield 

-


Market capitalisation 

£198.87 mn


P/E ratio 

68.81


ISIN 

GB00B9275X97


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Hvivo PLC- 1.03
FTSE AIM All Share+ 0.35
More...

Company profile

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202404:06:5629.231,000292.30
28/03/202403:56:1528.813,5001,008.35
28/03/202403:54:3329.2324,5317,170.41
28/03/202403:41:1828.92534,1649,881.94
28/03/202403:40:3629.283,8161,117.32

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.